Xie J, Wang Q, Xu Y, Zhang T, Chen L, Zuo X, et al. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(2):1928–49.

Article  PubMed  Google Scholar 

Metzger DW, Sun K. Immune dysfunction and bacterial coinfections following influenza. J Immunol. 2013;191(5):2047–52.

Article  CAS  PubMed  Google Scholar 

Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72(10):2097–111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almand EA, Moore MD, Jaykus LA. Virus-bacteria interactions: an emerging topic in human infection. Viruses. 2017. https://doi.org/10.3390/v9030058.

Article  PubMed  PubMed Central  Google Scholar 

Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–68.

Article  CAS  PubMed  Google Scholar 

Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7): e12560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340–50.

Article  CAS  PubMed  Google Scholar 

Peng JM, Du B, Qin HY, Wang Q, Shi Y. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients. J Infect. 2021;82(4):22–7.

Article  CAS  PubMed  Google Scholar 

Casto AM, Fredricks DN, Hill JA. Diagnosis of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics. Blood Rev. 2022;53: 100906.

Article  CAS  PubMed  Google Scholar 

Qi C, Hountras P, Pickens CO, Walter JM, Kruser JM, Singer BD, et al. Detection of respiratory pathogens in clinical samples using metagenomic shotgun sequencing. J Med Microbiol. 2019;68(7):996–1002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Feng W, Ye K, Guo L, Xia H, Guan Y, et al. Application of metagenomic next-generation sequencing in the diagnosis of pulmonary infectious pathogens from bronchoalveolar lavage samples. Front Cell Infect Microbiol. 2021;11: 541092.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.

Article  CAS  PubMed  Google Scholar 

Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American thoracic society/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.

Article  PubMed  PubMed Central  Google Scholar 

Park SW, Baek AR, Lee HL, Jeong SW, Yang SH, Kim YH, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 1. Introduction. Tuberc Respir Dis (Seoul). 2019;82(4):269–76.

Article  PubMed  Google Scholar 

Lee SH, Yeo Y, Kim TH, Lee HL, Lee JH, Park YB, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 2. Idiopathic Pulmonary Fibrosis. Tuberc Respir Dis (Seoul). 2019;82(2):102–17.

Article  PubMed  Google Scholar 

Coronavirus Disease 2019 (COVID-19) treatment guidelines. Bethesda (MD) 2021.

Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–14.

Article  PubMed  Google Scholar 

Cauley LS, Vella AT. Why is coinfection with influenza virus and bacteria so difficult to control? Discov Med. 2015;19(102):33–40.

PubMed  PubMed Central  Google Scholar 

Hendaus MA, Jomha FA. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn. 2021;39(11):4185–91.

Article  CAS  PubMed  Google Scholar 

Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Satyanarayana G, Enriquez KT, Sun T, Klein EJ, Abidi M, Advani SM, et al. Coinfections in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) study. Open Forum Infect Dis. 2022;9(3):ofac037.

Article  PubMed  PubMed Central  Google Scholar 

Saade A, Moratelli G, Dumas G, Mabrouki A, Tudesq JJ, Zafrani L, et al. Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect. Ann Intensiv Care. 2021;11(1):83.

Article  CAS  Google Scholar 

Park SY, Kim MY, Choi WJ, Yoon DH, Lee SO, Choi SH, et al. Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy. Med Mycol. 2017;55(4):349–57.

PubMed  Google Scholar 

Kim T, Choi SH, Kim SH, Jeong JY, Woo JH, Kim YS, et al. Point prevalence of pneumocystis pneumonia in patients with non-hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol. 2013;92(2):231–8.

Article  CAS  PubMed  Google Scholar 

Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneumocystis pneumonia in patients treated with rituximab. Chest. 2013;144(1):258–65.

Article  CAS  PubMed  Google Scholar 

Flori P, Bellete B, Durand F, Raberin H, Cazorla C, Hafid J, et al. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis Jiroveci pneumonia from bronchoalveolar lavage specimens. J Med Microbiol. 2004;53(Pt 7):603–7.

Article  CAS  PubMed  Google Scholar 

Brakemeier S, Pfau A, Zukunft B, Budde K, Nickel P. Prophylaxis and treatment of Pneumocystis jirovecii pneumonia after solid organ transplantation. Pharmacol Res. 2018;134:61–7.

Article  CAS  PubMed  Google Scholar 

Jin D, Le J, Yang Q, Cai Q, Dai H, Luo L, et al. Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology. Infect Agent Cancer. 2023;18(1):80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin P, Chen Y, Su S, Nan W, Zhou L, Zhou Y, et al. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients. BMC Infect Dis. 2022;22(1):416.

Article  PubMed  PubMed Central  Google Scholar 

Rothe K, Feihl S, Schneider J, Wallnofer F, Wurst M, Lukas M, et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2021;40(4):859–69.

Article  CAS  PubMed